KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $357000.0.

  • Fulgent Genetics' Gains from Investment Securities fell 1716.94% to $357000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 377.57%. This contributed to the annual value of $2.9 million for FY2024, which is 611.27% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Gains from Investment Securities is $357000.0, which was down 1716.94% from $345000.0 recorded in Q2 2025.
  • Fulgent Genetics' Gains from Investment Securities' 5-year high stood at $2.7 million during Q3 2021, with a 5-year trough of $71000.0 in Q4 2023.
  • Moreover, its 5-year median value for Gains from Investment Securities was $503500.0 (2021), whereas its average is $785722.2.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 112142.86% in 2021, then crashed by 8068.1% in 2022.
  • Over the past 5 years, Fulgent Genetics' Gains from Investment Securities (Quarter) stood at $688000.0 in 2021, then crashed by 54.07% to $316000.0 in 2022, then plummeted by 77.53% to $71000.0 in 2023, then soared by 240.85% to $242000.0 in 2024, then surged by 47.52% to $357000.0 in 2025.
  • Its Gains from Investment Securities stands at $357000.0 for Q3 2025, versus $345000.0 for Q2 2025 and $1.9 million for Q1 2025.